中国の血液疾患治療薬市場

中国の血液疾患治療薬の需要は、過去10年間に速いペースで伸びてきました。今後10年間も、生産と需要の両方が伸び続けると予測されています。中国経済は、工業生産高、輸出入、消費者消費、設備投資の20年以上にわたる連続的な増加によって刺激され、高速成長を維持しています。

当レポートでは、中国の血液疾患治療薬市場について調査し、中国の経済動向、投資環境、市場開拓、需給、産業能力、産業構造、マーケティングチャネル、主要な業界参入企業などを網羅しています。過去データ（2014年、2019年、2024年）と2029年、2034年までの長期予測とともに、中国の主要生産者のプロファイルを掲載しています。

目次

第1章 イントロダクション

第2章 ビジネス環境

• 経済見通し
• 主要経済指標
• 工業生産高
• 人口と労働
• 外国投資
• 貿易
• 金融および税務規制
• 銀行システムと規制
• 外国為替
• 税金、関税、通関手数料

第3章 血液疾患医薬品業界の評価

• 血液疾患治療薬業界の構造
• 市場規模
• 市場成長の原動力
• 血液疾患治療薬販売量
• 主要生産施設の所在地と販売量
• 主要生産者の市場シェア
• 人件費
• 潜在的な参加者
• 主要販売代理店
• 主要な外国投資
• 技術開発

第4章 血液疾患治療薬の生産と需要

• 概要
• 地域別血液疾患治療薬の需要
• 血液疾患治療薬販売量
• 貧血治療薬
• メコバラミン
• コバマミド
• コハク酸鉄
• 白血球原
• 好中球減少症および無顆粒球症の治療薬
• ビタミンB4
• バティロール
• イノシン
• デオキシリボヌクレオチド
• 副腎皮質ホルモン
• 顆粒球コロニー刺激因子（G-CSF）
• 白血病治療薬販売量
• インターフェロン
• イマチニブ
• リツキシマブ
• ピラルビシン
• ヒドロキシカンポテシン
• その他の血液疾患治療薬の販売量
• 血液疾患治療薬の輸入
• 貧血治療薬
• メコバラミン
• コバマミド
• コハク酸鉄
• 白血球原
• 好中球減少症および無顆粒球症治療薬の輸入
• ビタミンB4
• バティロール
• イノシン
• デオキシリボヌクレオチド
• 副腎皮質ホルモン
• 顆粒球コロニー刺激因子（G-CSF）
• 白血病治療薬の輸入
• インターフェロン
• イマチニブ
• リツキシマブ
• ピラルビシン
• ヒドロキシカンポテシン
• その他の血液疾患治療薬の輸入
• 価格動向

第5章 血液疾患治療薬市場の展望

• 血液疾患治療薬市場の展望概要
• 政府の規制
• 医療保険業界の概要
• 消費者支出動向
• ヘルスケア業界の動向
• 病院と病床

第6章 マーケティング戦略

• 中国市場参入の概要
• 中国の流通システム
• ゴム加工用化学薬品の流通経路
• 輸送・貨物インフラ
• 通信
• 中国の市場参入
• ライセンシング
• フランチャイズ
• eコマース
• 商社および現地代理店
• 駐在員事務所および中国子会社
• 100％外資企業

第7章 血液疾患治療薬製造者ディレクトリ

第1章 イントロダクション

• 経済見通しの概要

第2章 ビジネス環境

• 主要経済指標
• 工業生産高
• 人口と労働力の動向
• 外国投資と融資
• 貿易

第3章 血液疾患医薬品業界の評価

第4章 血液疾患治療薬の生産と需要

第5章 血液疾患治療薬市場の展望

ULIST OF CHARTS

I. NTRODUCTION

• Blood Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

• China's GDP and Industrial Output
• Industrial Output by Ownership
• China's Imports and Exports

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

• Anemia Treatment Drugs Sales Volume by Drugs Classification
• Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
• Leukemia Treatment Drugs Sales Volume by Drugs Classification
• Blood Disease Drugs Sales Volume

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

• Blood Disease Drugs Sales Volume
• Worldwide Blood Disease Drugs Demand by region
• Anemia Major Producer and Their Market Share
• Anemia Treatment Drugs Sales Volume by Drugs Classification
• Mecobalamin Sales Volume and Market Share
• Cobamamide Sales Volume and Market Share
• Ferrous Succinate Sales Volume and Market Share
• Leucogen Sales Volume and Market Share
• Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
• Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
• VitamineB4 Sales Volume and Market Share
• Batilol Sales Volume and Market Share
• Inosine Sales Volume and Market Share
• Deoxyribonucleotide Sales Volume and Market Share
• Adrenocortical Hormone Sales Volume and Market Share
• Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
• Leukemia Treatment Drugs Sales Volume and Market Share
• Leukemia Treatment Drugs Sales Volume by Drugs Classification
• Interferon Sales Volume and Market Share
• Imatinib Mesylate Sales Volume and Market Share
• Rituximab Sales Volume and Market Share
• Pirarubicin Sales Volume and Market Share
• Hydroxycampothecin Sales Volume and Market Share
• Other Blood Disease Drugs Sales volume and Market Share
• Blood Disease Drugs Import Volume
• Anemia Import Volume and Market Share
• Anemia Treatment Drugs Import Volume by Drugs Classification
• Mecobalamin Import Volume and Market Share
• Cobamamide Import Volume and Market Share
• Ferrous Succinate Import Volume and Market Share
• Leucogen Import Volume and Market Share
• Galanthamine Import Volume and Market Share
• Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
• Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
• VitamineB4 Import Volume and Market Share
• Batilol Import Volume and Market Share
• Inosine Import Volume and Market Share
• Deoxyribonucleotide Import Volume and Market Share
• Adrenocortical Hormone Import Volume and Market Share
• Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
• Leukemia Treatment Drugs Import Volume and Market Share
• Leukemia Treatment Drugs Import Volume by Drugs Classification
• Interferon Treatment Drugs Import Volume and Market Share
• Imatinib Mesylate Treatment Drugs Import Volume and Market Share
• Rituximab Treatment Drugs Import Volume and Market Share
• Pirarubicin Treatment Drugs Import Volume and Market Share
• Hydroxycampothecin Treatment Drugs Import Volume and Market Share
• Other Blood Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

• China's Distribution Channel

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2014, 2019 and 2024) and long-term forecasts through 2029 and 2034 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population and Labor
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

• Blood Disease Drugs Industry Structure
• Market Size
• Market Growth Drivers
• Blood Disease Drugs Sales Volume
• Major Producer Facility Locations and Sales Volume
• Market Share of Key Producers
• Labor Cost
• Potential Entrants
• Major Distributors
• Major Foreign Investment
• Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

• Overview
• Demand of Blood Disease Drugs by Region
• Blood Disease Drugs Sales Volume
• Anemia Treatment Drugs
• Mecobalamin
• Cobamamide
• Ferrous Succinate
• Leucogen
• Neutropenia and Agranulocytosis Treatment Drugs
• VitamineB4
• Batilol
• Inosine
• Deoxyribonucleotide
• Adrenocortical Hormone
• Granulocyte Colony-Stimulating Factor(G-CSF)
• Leukemia Treatment Drugs Sales Volume
• Interferon
• Imatinib
• Rituximab
• Pirarubicin
• Hydroxycampothecin
• Other Blood Disease Drugs Sales Volume
• Blood Disease Drugs Imports
• Anemia Treatment Drugs
• Mecobalamin
• Cobamamide
• Ferrous Succinate
• Leucogen
• Neutropenia and Agranulocytosis Treatment Drugs Imports
• VitamineB4
• Batilol
• Inosine
• Deoxyribonucleotide
• Adrenocortical Hormone
• Granulocyte Colony-Stimulating Factor(G-CSF)
• Leukemia Treatment Drugs Imports
• Interferon
• Imatinib
• Rituximab
• Pirarubicin
• Hydroxycampothecin
• Other Blood Disease Drugs Imports
• Pricing Trends

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

• Blood Disease Drugs Market Outlook Overview
• Government Regulation
• Health Care Insurance Industry Overview
• Consumer Spending Trends
• Northeast
• North
• Southeast
• Central
• Southwest
• Northwest
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

• China Market Entry Overview
• China's Distribution System
• Rubber Processing Chemicals Distribution Channels
• Transportation and Freight Infrastructure
• Communications
• China's Market Entry
• Licensing
• Franchising
• E-commerce
• Trading Companies and Local Agents
• Representative Offices and Chinese Subsidiaries
• Wholly Foreign Owned Enterprises

VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY

• Blood Disease Drugs Producer Profiles
• Distributors and Trading Companies
• Research Institutions and Associations
• ULIST OF TABLES

I. INTRODUCTION

• Economic Outlook Summary

II. BUSINESS ENVIRONMENT

• Key Economic Indicators
• Industrial Output
• Population and Labor Force Trends
• Foreign Investment and Loans
• Foreign Trade

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

• Anemia Treatment Drugs Sales Volume by Drugs Classification
• Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
• Leukemia Treatment Drugs Sales Volume by Drugs Classification
• Blood Disease Drugs Sales Volume
• Major Producer Facility Location
• Major Blood Disease Drugs Producer Sales Volume
• Market Share of Key Producers
• Major Foreign Investment in China

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

• Total Blood Disease Drugs Sales Volume
• Blood Disease Drugs Major Producer and Their Market Share
• Anemia Major Producer and Their Market Share
• Anemia Treatment Drugs Sales Volume by Drugs Classification
• Anemia Treatment Drugs Major Producer and Their Market Share
• Mecobalamin Major Producer and Their Market Share
• Cobamamide Major Producer and Their Market Share
• Ferrous Succinate Major Producer and Their Market Share
• Leucogen Major Producer and Their Market Share
• Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
• Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
• VitamineB4 Major Producer and Their Market Share
• Batilol Major Producer and Their Market Share
• Inosine Major Producer and Their Market Share
• Deoxyribonucleotide Major Producer and Their Market Share
• Adrenocortical Hormone Major Producer and Their Market Share
• Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
• Leukemia Treatment Drugs Major Producer and Their Market Share
• Leukemia Treatment Drugs Sales Volume by Drugs Classification
• Interferon Major Producers and Their Market Share
• Imatinib Mesylate Major Producer and Their Market Share
• Rituximab Major Producer and Their Market Share
• Pirarubicin Major Producer and Their Market Share
• Hydroxycampothecin Major Producer and Their Market Share
• Blood Disease Drugs Import
• Anemia Treatment Drugs Import Volume by Drugs Classification
• Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
• Leukemia Treatment Drugs Import Volume by Drugs Classification

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

• Consumer Spending Trend
• The Structure of Per Capita Expenditure in the Northeast of China
• The Structure of Per Capita Expenditure in the North of China
• The Structure of Per Capita Expenditure in the Southeast of China
• The Structure of Per Capita Expenditure in the Central of China
• The Structure of Per Capita Expenditure in the Southwest of China
• The Structure of Per Capita Expenditure in the Northwest of China
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds